Centre Hospitalier Intercommunal Creteil — Clinical Trial Site

173 Registered trials

82 Currently recruiting

Organisation

Centre Hospitalier Intercommunal Creteil

Location

Creteil, France

Identifier

ORG-100042860

Address

40 Avenue De Verdun, 94010, France

Departments

#2303:Service de Pédiatrie
2304:Service de Pneumologie
250005: Service Ophtalmologie
3205: Ophtalmology
94000
94010
CHI Créteil - Pneumologie
Consultation pediatrique
Creteil CHIC (enfants)
Département de Pneumologie
DERMATOLOGIE
Dermatology
Dermatology department
digestive oncology
FRA009: Centre de Coordination en Cancérologie
gastroenterology
gynecology
hépatogastroentérologie
Hepatogastroenterology
INFECTIOLOGY
Intensive care
Internal medecine
Internal Medicine
Maladies infectieuses et Tropicales
Maternité
Médecine interne
Medical onclogy
Medical oncology
N/A
Néonatologie
Neonatology
Obstetric gynecology
Obstetrics
ONCOLOGIE
ONCOLOGIE MEDICALE
Oncologie-Radiothérapie
oncology
Oncology-Radiotherapy
Ophtalmologie
Ophtalmology
Ophthalmology
Ophthalmology Department
Orthopédie
Paediatrics
Pédiatrie
Pédiatrie Générale
PMA
Pneumologie
Pneumologie / UFR Sante Medecine
Pneumologie Batiment U
Pneumologie Oncologie thoracique
Pneumology
Pneumology and Thoracic Oncology
Pneumology department
Pneumonology
Public health and Social Medicine
Pulmonology
Radiothérapie
Radiotherapy
Radiotherapy -Oncology
Réanimation médicale
Service d'Hepato-Gastro-Enterologie
Service d'Hépatologie
Service d'Ophtalomologie
Service d’ophtalmologie
Service de gastroentérologie et hépatologie
Service de gynécologie obstétrique, - unité de médecine de la reproduction
Service de Médecine Interne
Service de Pediatrie
Service de pédiatrie - Hôpital de jour
Service de Pneumologie
Service de pneumologie; Service de pédiatrie
Service Hepato-gastroenterologie
Service Ophtalmologie
Service Pédiatrie - Reference centres for SCD
Service Pneumologie
Service pneumology
Urgences pédiatriques

Clinical trials at this site (173)

Search interface

Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chem… Ended

2023-505773-32-00 Untreated Metastatic Non-Squamous Non-Small Cell Lung C 10 2025-03-25
BMS-986489 (BMS-986012 + Nivolumab Fixed Dose Combination) with Chemotherapy vs Atezolizumab with Chemotherapy as First-line Therapy in Part… Ended

2024-515740-23-00 Extensive-Stage Small Cell Lung Cancer (ES-SCLC) 5 2025-03-25
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Participants with Dry Age-Related Macular Degeneration… Ended

2024-515022-88-00 Dry Age-Related Macular Degeneration (AMD) with geograp 5 2025-03-03
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended

2024-512998-27-00 Non-Small Cell Lung Cancer 5 2025-02-21
A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL C… Ended

2024-514032-25-00 Patients with a histilogically confirmed diagnosis of c 4 2024-12-11
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 10 2024-11-22
An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Ended

2024-512113-41-00 Severe Asthma 5 2024-11-20
A Phase 2 Trial of Combination Therapies with Adagrasib in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation Ended

2023-503714-77-00 Advanced Non-Small Cell Lung Cancer 4 2024-10-01
HARMONi-3 Ended

2024-513087-26-00 Metastatic Non-small Cell Lung Cancer 5 2024-09-10
Efficacy and safety of subcutaneous dupilumab in participants with asthma/asthmatic wheeze aged 2 to <6 years Ended

2023-504331-41-00 Respiratory tract diseases - Wheezing, Asthma 5 2024-08-02
Ovulation induction and luteal phase support with GnRH agonists in in vitro fertilization Ended

2023-505126-34-00 IVF (In vitro fertilization) or ICSI (intracytoplasmic 5 2024-06-27
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participan… Ended

2023-503666-23-00 Neovascular age-related macular degeneration 5 2024-06-07
Phase III Trial of Volrustomig (MEDI5752) in Combination with Carboplatin plus Pemetrexed vs. Investigator’s Choice of the Standard of Care … Ended

2023-503231-17-00 Unresectable Pleural Mesothelioma 5 2024-04-26
A study of sigvotatug vedotin versus docetaxel in previously treated non-small cell lung cancer (Be6A Lung-01) Ended

2023-503827-25-01 Non-Small Cell Lung Cancer (NSCLC) 5 2024-02-16
Tuvusertib (M1774) in Combination with Cemiplimab in Participants with Non-Squamous NSCLC (DDRiver NSCLC 322) Ended

2022-502010-85-00 Non-Squamous Non-Small Cell Lung Cancer 9 2023-12-20
A Phase 3 Study of Front‑line Platinum Doublet Therapy With Sotorasib Versus Pembrolizumab in PD-L1 Negative KRAS p.G12C Positive Advanced/M… Ended

2022-501863-41-00 Subjects With Stage IV or Advanced Stage IIIB/C Nonsqua 5 2023-11-13
Effect of study drug combined with chemotherapy in patients with locally advanced or metastatic lung cancer with mutated receptor responsibl… Ended

2023-504434-22-00 Patients With EGFR-mutant Locally Advanced or Metastati 5 2023-10-03
A study to assess efficacy and safety of benralizumab in paediatric patients with severe eosinophilic asthma (severe asthma marked by high… Ended

2022-501344-14-00 Paediatric Patients with Severe Eosinophilic Asthma Ast 5 2023-06-05
IFCT-2201 ADAPTABLE A study evaluating the combination of paclitaxel-bevacizumab ± atezolizumab in patients with advanced lung cancer progre… Ended

2022-502103-30-00 advanced non-squamous non-small cell lung cancer 4 2023-04-25
A clinical trial to compare the effectiveness of savolitinib plus osimertinib versus chemotherapy for the treatment of non-small cell lung c… Ended

2024-511169-12-00 Non-Small Cell Lung Cancer 5 2023-03-28
Durvalumab (immunotherapy) maintenance after thoracic chemoradiotherapy (CRT) in frail small cell lung cancer patients whose disease is limi… Ended

2024-512224-11-00 Histologically confirmed frail Limited Disease Small Ce 4 2023-03-24
A Phase 3 Study of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Ended

2024-514173-22-00 Cystic Fibrosis 5 2023-02-28
A Study of Dato-DXd in Combination With Durvalumab and Carboplatin for First-line Treatment of Advanced NSCLC Without Actionable Genomic Alt… Ended

2023-505993-14-00 Non-Small Cell Lung Cancer (NSCLC) 5 2023-01-05
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor Long-term Safety and Efficacy in Subjects Without F508del Ended

2024-515637-14-00 Cystic Fibrosis 5 2022-11-08